Tag: Non-small-cell lung cancer

May 7, 2026

Acknowledgments to Shanghai Collaborative Innovation Center for Translational Medicine and L. Zheng (Children’s National Medical Center)

April 20, 2026

Proteomics Analysis Support in Shanghai

February 6, 2026

Lung Cancer Treatment Timing: Earlier Immunochemotherapy Boosts Survival Rates

February 4, 2026

Repotrectinib Shows Durable Response in NTRK Fusion–Positive Advanced Solid Tumors – TRIDENT-1 Trial

October 24, 2025

COVID mRNA Vaccines and Cancer Treatment Effectiveness

September 8, 2025

Adjuvant Chemo-Immunotherapy for NSCLC Patients

September 8, 2025

FDA Breakthrough Therapy Designation for Olomorasib + Pembrolizumab in NSCLC

September 7, 2025

Antibody-Drug Conjugates in NSCLC Treatment: A Growing Role

September 2, 2025

Rare NSCLC Subtypes & Targeted Therapy: Learning Curves

August 19, 2025

Sacituzumab Tirumotecan + Tagitanlimab for Advanced NSCLC

August 10, 2025

Zongertinib FDA Approved: NSCLC Treatment for HER2 TKD Mutations

July 30, 2025

Exosome Stiffness for Lung Cancer Gene Detection

July 9, 2025

Lung Cancer Biomarker Detection: AI Pathology Model

June 9, 2025

Neoadjuvant Nivolumab NSCLC: Improved Survival Rates

June 2, 2025

Lung Cancer Therapy Side Effects: CRS, ICANS & Skin Reactions

May 30, 2025

NSCLC & Skin Health: Improving Quality of Life